Anti-malarial market and policy surveys in sub-Saharan Africa

Malaria Journal

Volumn 9, Issue SUPPL. 1, 2010, Pages

  Diap, Graciela ^a   Amuasi, John ^b   Boakye, Isaac ^b   Sevcsik, Ann Marie ^a   Pecoul, Bernard ^a  

^a Drugs for Neglected Diseases Initiative DNDi   (Switzerland)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; HALOFANTRINE; QUININE; ARTEMISININ DERIVATIVE;

AFRICA; CONFERENCE PAPER; DRUG COST; DRUG MARKETING; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MALARIA; MALARIA CONTROL; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; ARTICLE; BURUNDI; DRUG COMBINATION; ECONOMICS; INFORMATION PROCESSING; MARKETING; SIERRA LEONE; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; ARTEMISININS; BURUNDI; DATA COLLECTION; DRUG THERAPY, COMBINATION; HEALTH POLICY; HUMANS; MALARIA; MARKETING; PRIVATE SECTOR; PUBLIC SECTOR; SIERRA LEONE; WORLD HEALTH ORGANIZATION;

EID: 77951568863     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-S1-S1     Document Type: Conference Paper

References (25)

1. World Malaria Report. World Health Organization (WHO), 2009 http://whqlibdoc.who.int/publications/2009/9789241563901-eng.pdf
2. Antimalarial Drug Combination Therapy - Report of a WHO Technical Consultation. 2001 http://www.who.int/malaria/publications/atoz/who-cds-rbm- 2001-35/en/index.html
3. World Malaria Report. World Health Organization (WHO), 2009 http://www.who.int/malaria/world-malaria-report-2009/en/index.html
4. World Health Organization (WHO), http://www.who.int/malaria/publications/ treatment-policies/en/index.html
5. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. CJ Whitty C Chandler E Ansah T Leslie SG Staedke, Malar J 2008 7 Suppl 1 7
6. The story of ASAQ: the first antimalarial product development partnership success. B Pécoul A Sevcsik J Amuasi G Diap JR Kiechel, Health Partnerships Rev 2008 77
7. http://www.actwithasaq.org
8. World Health Organization (WHO), http://www.who.int/medicines/areas/ access/medicines-prices08/en/index.html
9. Community coverage of an antimalarial combination of AS and amodiaquine in Makamba Province, Burundi, nine months after its introduction. S Gerstl S Cohuet K Edoh C Brasher A Lesage JP Guthmann F Checchi, Malar J 2007 6 94 (Pubitemid 47256395)
10. Death rates from malaria epidemics, Burundi and Ethiopia. JP Guthmann M Bonnet L Ahoua F Dantoine S Balkan M van Herp A Tamrat D Legros V Brown F Checchi, Emerg Infect Dis 2007 13 140 143 (Pubitemid 46057852)
11. Plan National De Développement Sanitaire 2006-2010. République de Burundi Ministère de la Sante Publique, 2006
12. La prise en charge du paludisme au Burundi: module de formation l intention des prestataires des soins. Bujumbura, Burundi. Ministère de la Sante Publique, 2003
13. Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base. O Bouchaud P Imbert JE Touze AN Dodoo M Danis F Legros, Malar J 2009 8 289
14. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. LK Basco R Tahar P Ringwald, Antimicrob Agents Chemother 1998 42 1811 1814 (Pubitemid 28311584)
15. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. B Pradines P Hovette T Fusai HL Atanda E Baret P Cheval J Mosnier A Callec J Cren R Amalvict JP Gardair C Rogier, J Clin Microbiol 2006 44 2404 2408 (Pubitemid 44092404)
16. National Health Sector Strategic Plan, 2010-15. Sierra Leone Government, Ministry of Health and Sanitation 2009
17. Malaria Baseline Survey. National Malaria Control Programme. Sierra Leone Government, Ministry of Health and Sanitation 2005
18. Malaria case management: operations manual. World Health Organisation (WHO), 2009 http://www.who.int/malaria/publications/atoz/9789241598088/en/index. html
19. World Health Organisation (WHO), http://www.who.int/malaria/publications/ atoz/malaria-case-management-operations-manual.pdf
20. Early results of integrated malaria control and implications for the management of fever in under-five children at a peripheral health facility: a case study of Chongwe rural health centre in Zambia. P Chanda B Hamainza S Mulenga V Chalwe C Msiska E Chizema-Kawesha, Malar J 2009 8 49
21. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. KI Barnes P Chanda G Ab Barnabas, Malar J 2009 8 Suppl 1 8
22. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. D Zurovac JK Tibenderana J Nankabirwa J Ssekitooleko JN Njogu JB Rwakimari S Meek A Talisuna RW Snow, Malar J 2008 7 181
23. Cost of increasing access to artemisinin combination therapy: the Cambodian experience. S Yeung W Van Damme D Socheat NJ White A Mills, Malar J 2008 7 84 (Pubitemid 351945028)
24. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. H Hopkins A Talisuna CJ Whitty SG Staedke, Malar J 2007 6 134
25. Unforgettable launch of MMV-MOH Uganda Pilot. Medicines for Malaria Venture (MMV), http://www.mmv.org/article.php3?id-article=527